UPDATE: Piper Jaffray Initiates Coverage On Aratana Therapeutics Inc On Approaching Catalysts

By: via Benzinga
In a report published Tuesday, Piper Jaffray analyst Kevin K. Ellich initiated coverage on Aratana Therapeutics Inc (NASDAQ: PETX) with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.